The Fanconi Anemia Group C Gene Product is Located in Both the Nucleus and Cytoplasm of Human Cells
Overview
Authors
Affiliations
The Fanconi anemia (FA) complementation group C (FAC) protein gene encodes a cytoplasmic protein with a predicted Mr of 63,000. The protein's function is unknown, but it has been hypothesized that it either mediates resistance to DNA cross-linking agents or facilitates repair after exposure to such factors. The protein also plays a permissive role in the growth of colony-forming unit-granulocyte/macrophage (CFU-GM), burst-forming unit-erythroid (BFU-E), and CFU-erythroid (CFU-E). Attributing a specific function to this protein requires an understanding of its intracellular location. Recognizing that prior study has established the functional importance of its cytoplasmic location, we tested the hypothesis that FAC protein can also be found in the nucleus. Purified recombinant Escherichia coli-derived FAC antigens were used to create antisera able to specifically identify an Mr = 58,000 protein in lysates from human Epstein-Barr virus (EBV)-transformed cell lines by immunoblot analysis. Subcellular fractionation of the cell lysates followed by immunoblot analysis revealed that the majority of the FAC protein was cytoplasmic, as reported previously; however, approximately 10% of FAC protein was reproducibly detected in nuclear fractions. These results were reproducible by two different fractionation methods, and included markers to control for contamination of nuclear fractions by cytoplasmic proteins. Moreover, confocal image analysis of human 293 cells engineered to express FAC clearly demonstrated that FAC protein is located in both cytoplasmic and nuclear compartments, consistent with data obtained from fractionation of the FA cell lines. Finally, complementation of the FAC defect using retroviral-mediated gene transfer resulted in a substantial increase in nuclear FAC protein. Therefore, while cytoplasmic localization of this protein appears to be functionally important, it may also exert some essential nuclear function.
A Narrative Review on Fanconi Anemia: Genetic and Diagnostic Considerations.
Sharma P, Sharma N, Sharma D Glob Med Genet. 2022; 9(3):237-241.
PMID: 36071913 PMC: 9444348. DOI: 10.1055/s-0042-1751303.
The Fanconi anemia group C protein interacts with uncoordinated 5A and delays apoptosis.
Huang F, Ben Aissa M, Magron A, C Huard C, Godin C, Levesque G PLoS One. 2014; 9(3):e92811.
PMID: 24676280 PMC: 3968024. DOI: 10.1371/journal.pone.0092811.
Fanconi anemia proteins and their interacting partners: a molecular puzzle.
Kaddar T, Carreau M Anemia. 2012; 2012:425814.
PMID: 22737580 PMC: 3378961. DOI: 10.1155/2012/425814.
Du W, Li J, Sipple J, Chen J, Pang Q J Biol Chem. 2010; 285(48):37436-44.
PMID: 20864535 PMC: 2988349. DOI: 10.1074/jbc.M110.113209.
FANCE: the link between Fanconi anaemia complex assembly and activity.
Pace P, Johnson M, Tan W, Mosedale G, Sng C, Hoatlin M EMBO J. 2002; 21(13):3414-23.
PMID: 12093742 PMC: 125396. DOI: 10.1093/emboj/cdf355.